Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on PFIZER INC
03:06p SPARK THERAPEUTICS : and Pfizer Announce Updated Data from First Cohort in Hemop..
01:14p PFIZER : Global Citizen and Pfizer - Convention
09:51a Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
07/25 APNEWSBREAK : Pfizer: Arkansas execution would 'misuse' drug
07/24 PFIZER : Labour proposes scrapping £1bn tax relief for innovation
07/23 SPARK THERAPEUTICS : and Pfizer Announce Receipt of FDA Breakthrough Therapy Des..
07/22 PFIZER : Lasco Distributors Limited and Medimpex Jamaica Limited to face Pfizer ..
07/22 PFIZER : Global Citizen and Pfizer - Convention
07/22 SPARK THERAPEUTICS : and Pfizer Announce Receipt of FDA Breakthrough Therapy Des..
07/22 PFIZER : Corbyn warns rebellious Labour MPs of deselection
07/21 PFIZER : Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT..
07/21 PFIZER : Challenger committed to free health
07/21 PFIZER : Marcus Carr, Vice President at Pfizer to Keynote at GTCbio’s Cell..
07/20 PFIZER : Pharmaceutical giant Pfizer confirms Irish expansion, to add 350 new jo..
07/20 PFIZER : Lasco Distributors, Pfizer valuation lawsuit adjourned
07/20 U.S. healthcare stock bulls look past political risks
07/20 PFIZER : Receives World Health Organization Prequalification for Multi-Dose Vial..
07/19 PFIZER : Owen Smith worked as PR chief for biotech firm hit by $762m fine
07/19 Indian pharma majors fail drug test
07/19 SoftBank bid for ARM catches some hedge funds off guard
07/19 PFIZER : Receives World Health Organization Prequalification for Multi-Dose Vial..
07/19 PFIZER : Hua Xu, Principal Scientist at Pfizer, to Present at Drug Design & Medi..
07/18 PFIZER : Global Citizen and Pfizer - Convention
07/18 PFIZER : Russia Deal Shows Country Still Open To Western Business
07/18 PFIZER : Alum Takes Fight for Transgender Rights to Political Conventions
07/18 PFIZER : ARIA Study Shows Superior Efficacy of Triumeq® for Treatment-naïve Wome..
07/15 SWEDISH ORPHAN BIOVITRUM PUBL : Sobi publishes its report for the second quarter..
07/14 PFIZER : AGA and Pfizer Inc. call on scientists to offer new approaches to IBD r..
07/14 PFIZER : Seeks to Increase Patient Access to Medicines
07/13 PFIZER : FDA approves label expansion for Pfizer’s Prevnar 13
07/13 PFIZER : Announces the Publication of Final Results from Two Pivotal Phase 3 Stu..
07/12DJAmgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12DJCorrection to Juno to Resume Clinical Trial Article
07/12DJJuno to Resume Clinical Trial of Anticancer Treatment
07/12DJMerck to Cut Research Jobs at Three East-Coast Sites
07/12DJMerck & Co. Cutting Drug Research Jobs at 3 East-Coast Sites in Latest Shake-..
07/11 Astra weighs $10bn bid for prostate cancer drug developer
07/10 PFIZER : Richard Buller, VP at Pfizer, to Give a Keynote at GTCbio’s Bioma..
07/09 EXCLUSIVE - WELLCARE, CENTENE MAKE O : sources
07/08DJBill Ackman's Pershing Square Sells Off Another 6 Million Shares in Zoetis
07/08 PFIZER : NICE approves first drug from old Cancer Drugs Fund
07/08DJPFIZER : Sutent Study Meets Endpoint in Kidney Cancer Trial
07/08 PFIZER : Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT..
07/07 PFIZER : inVentiv Health Selected By Pfizer As Preferred Provider For Global Cli..
07/07DJJuno Shares Plunge as Drug Trial Placed on Hold After Patient Deaths
07/07 PFIZER : Completes Acquisition of Anacor
07/07 PFIZER : Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Po..
07/07 PFIZER : Advances Biosimilars Leadership with Investment in a New World-Class Gl..
07/07 PFIZER : NICE says ‘yes ‘ to bosutinib for chronic myeloid leukaemia
07/06 PFIZER : Biopharmaceutical giant Pfizer plans on expanding Grange Castle facilit..
07/06 PFIZER : 2015 Annual Review Showcases Commitment to Patient Assistance
07/06 PFIZER : agrees to note addiction risks in opioid marketing
07/06 PFIZER : The Kaiser Family Foundation (KFF) - Web event
07/06 MERCK KGAA : Phase III trial to evaluate avelumab as first-line treatment in ova..
07/06 INVESTORSOBSERVER : releases covered-call reports for Bank of America, Pfizer In..
07/06 PFIZER : Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First..
07/06 PFIZER : Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to ..
07/06DJBiotech Medivation Opens Door to Takeover Talks -- WSJ
07/05DJSanofi, Medivation Start Takeover Talks -- 2nd Update
07/05DJMedivation Opens Door to Takeover Talks With Sanofi
07/05 PFIZER : Highlights Role of Health in Achieving the UN’s Global Goals for ..
07/05 DBV TECHNOLOGIES : Proudly Welcomes Dr. Lucia Septien as Chief Medical Officer
07/02 PFIZER : Quarterly results - pfizer limited
07/01 PFIZER : The Kaiser Family Foundation (KFF) - Web event
06/30 PFIZER : Patent Issued for Use of Ghrelin Receptor Inverse Agonists Or Antagonis..
06/30 PFIZER : Patent Issued for Sildenafil Sublingual Spray Formulation (USPTO 937051..
06/30 AHF : Key Syphilis Medication in Short Supply Despite Increase in Infections
06/29 A SECOND MODULAR BIOPHARMA FACILITY : KUBio in Hangzhou
06/29 Pfizer bolsters China presence with $350m plant for biotech
06/29 Pfizer bolsters China presence with $350m plant for biotech
06/29 Pfizer bolsters China presence with $350m plant for biotech
06/28 PFIZER : SPIRE-HR and SPIRE-FH trials of bococizumab meet primary endpoints
06/28 PFIZER : invests big in biosimilar production in China
06/28 PFIZER : Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Po..
06/28 Imperial Innovations Says Storm Therapeutics Raises New Funds
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2016 52 660 M
EBIT 2016 19 337 M
Net income 2016 11 573 M
Debt 2016 17 470 M
Yield 2016 3,24%
P/E ratio 2016 20,53
P/E ratio 2017 17,06
EV / Sales 2016 4,57x
EV / Sales 2017 4,39x
Capitalization 223 065 M
More Financials
Chart PFIZER INC
Duration : Period :
Pfizer Inc Technical Analysis Chart | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 39,0 $
Spread / Average Target 6,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Mikael Dolsten President-Worldwide Research & Development
W. Don Cornwell Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC13.96%223 065
JOHNSON & JOHNSON21.58%343 528
PFIZER INC.13.94%223 065
NOVARTIS AG-5.13%218 815
ROCHE HOLDING LTD.-9.62%217 668
MERCK & CO., INC.10.87%162 096
More Results